REMEDY PLAN THERAPEUTICS
Remedy Plan Therapeutics is a pre-clinical-stage company developing small molecule therapeutics to halt tumor growth and disrupt the cancer stem cells that cause metastasis. Our approach is to develop effective, non-toxic treatments that target the dangerous embryonic properties of cancer stem cells, which form the basis for cancer growth, spread, and resistance to chemotherapy. Remedy Plan is positioned to deliver one first-in-class drug candidate for Phase I clinical development approximately ... 15 months after Series A funding Remedy Plan's proprietary drug screening platform identifies drug candidates that differentiate cancer stem cells, disrupt proliferation, and inhibit formation of new tumors. From the initial screen of 40,000 drug components, a lead candidate is currently undergoing optimization and mechanism of action studies in preparation for Phase I clinical trials. With the second screen of over 100,000 drug components completed, Remedy Plan aims to have at least two drugs in clinical development by 2020.
REMEDY PLAN THERAPEUTICS
Industry:
Biotechnology Health Diagnostics Medical Therapeutics
Founded:
2011-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.remedyplan.com
Total Employee:
1+
Status:
Active
Contact:
240-459-3985
Email Addresses:
[email protected]
Total Funding:
10.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Euro Microsoft Exchange Online
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Animated Dynamics
Animated Dynamics (AniDyn) Inc. is located in the Kurz Purdue Technology Center in West Lafayette IN.
Chronix Biomedical
Chronix Biomedical is a molecular diagnostics company developing blood tests for monitoring minimal residual disease in cancer patients.
LexaGene
LexaGene is a molecular diagnostics company that develops the MiQLab™ system for the detection of pathogens and other molecular markers.
MedChem Partners
MedChem Partners is a medicinal chemistry CRO that specializes in developing small molecule therapeutics.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Sunny Dental
Sunny Dental providing more professional orthodontics, implants, prosthetics, children's oral cavity and dental pulp.
Tisenc
Tisenc is engaged in the R&D and production of single-person automatic chemiluminescence analyzer.
Trice Orthopedics
Trice was founded to fundamentally improve orthopedic diagnostics and therapeutics by enabling instant and accurate office-based procedures.
Xcell Biosciences
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Current Advisors List
Current Employees Featured
Founder
Investors List
Schooner Capital
Schooner Capital investment in Venture Round - Remedy Plan Therapeutics
Official Site Inspections
http://www.remedyplan.com
- Host name: 172.67.200.226
- IP address: 172.67.200.226
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Remedy Plan Therapeutics"
Remedy Plan
Remedy Plan is a biotechnology company developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.See details»
Remedy Plan Therapeutics - Crunchbase Company …
Contact Email [email protected] Phone Number 240-408-4854 Remedy Plan Therapeutics is a pre-clinical-stage company developing small molecule …See details»
Team- Remedy Plan
Banu has over a decade of experience leading drug discovery programs and initiatives, with expertise across a wide range of diseases spanning immune, metabolic, and rare diseases …See details»
Remedy Plan Therapeutics - LinkedIn
Our CEO & Founder, Gregory Crimmins, COO, Dennise A. De Jesús-Díaz, and Executive VP of R&D Michael Schelle will be presenting a poster highlighting new data on Remedy Plan's first-in-class ...See details»
Remedy Plan Therapeutics - Org Chart, Teams, Culture & Jobs
View Remedy Plan Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Remedy Plan Therapeutics - PitchBook
Sep 21, 2018 Remedy Plan Therapeutics General Information Description. Developer of medical drugs designed to halt tumor growth and prevent cancer. The company's drugs disrupt cancer …See details»
Remedy Plan Therapeutics Company Overview, Contact Details ...
Aug 10, 2023 Remedyplan hires Cassandra Choe-Juliak. Remedy Plan Therapeutics ("Remedy Plan"), a small molecule therapeutics start-up company transforming the field of NAMPT …See details»
Remedy Plan - Craft
Remedy Plan $10.1 m in total funding,. See insights on Remedy Plan including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Remedy Plan Therapeutics Expands Leadership Team and Board
Dec 6, 2023 GAITHERSBURG, MD / ACCESSWIRE / December 6, 2023 / Remedy Plan Therapeutics (“Remedy Plan”), a small molecule therapeutics start-up company transforming …See details»
Remedy Plan - Products, Competitors, Financials, Employees ...
About Remedy Plan. Remedy Plan is a biotechnology company focused on developing novel therapeutics in the field of NAMPT inhibition. The company's main offerings include a …See details»
Currently Hiring - Remedy Plan
Remedy Plan is a team of scientists and biotech entrepreneurs dedicated to tackling the biggest health problem of our time. Meet the TeamSee details»
Remedy Plan CEO and Key Executive Team | Craft.co
Remedy Plan's Chief Executive Officer, Founder is Greg Crimmins. Other executives include Dennise A. de Jesús-Díaz, Chief Operations Officer; Yushma Bhurruth-Alcor, Director, …See details»
Remedy Plan - Overview, News & Similar companies - ZoomInfo
Popular Searches Remedy Plan Remedy Plan Inc Remedy Plan Therapeutics Remedyplan Remedy Plan - Inc SIC Code 87,873 NAICS Code 54,541 Show more. Remedy Plan Org …See details»
Remedy Plan Therapeutics - VentureRadar
Website: http://www.remedyplan.com. Remedy Plan is developing the first drugs that halt tumor growth and disrupt the cancer stem cells that cause metastasis.See details»
Remedy Plan, Inc. (Remedy Plan, Inc.) - 药物管线_专利_临床试验_ …
了解Remedy Plan, Inc. (Remedy Plan, Inc.)公司的药物管线，治疗领域，技术平台，以及它的1项临床试, 1篇新闻，疾病领域:肿瘤，免疫系统疾病，血液及淋巴系统疾病，内分泌与代谢疾 …See details»
Remedy Plan Therapeutics Expands Leadership Team and Board of …
Dec 7, 2023 GAITHERSBURG, MD / ACCESSWIRE / December 6, 2023 / Remedy Plan Therapeutics ('Remedy Plan'), a small molecule therapeutics start-up company transforming …See details»
Remedy Plan Therapeutics to Showcase Novel NAMPT Inhibitor …
Dec 10, 2023 /PRNewswire/ -- Remedy Plan Therapeutics ("Remedy Plan"), a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, today...See details»
Remedy Plan Therapeutics - VentureRadar
Similar Companies: COARE Biotechnology USA n/a COARE Biotechnology has several novel therapeutic technologies aimed at eradicating cancer stem cells and associated metastatic …See details»
Remedy Plan Therapeutics Expands Leadership Team and Board of …
Dec 6, 2023 GAITHERSBURG, MD / ACCESSWIRE / December 6, 2023 / Remedy Plan Therapeutics ("Remedy Plan"), a small molecule therapeutics start-up company transforming …See details»
How Remedy Place Is Transforming Wellness With Design ... - Forbes
1 day ago Step inside Remedy Place’s stunning new Boston location—its largest yet—and explore how this modern wellness club blends design, technology, and community to elevate …See details»